John Vavricka has sold AVIR and made no open-market buys since Feb 2024
Chief Commercial Officer at Atea Pharmaceuticals, Inc.
SEC CIK 0001829630 · Filings on SEC.gov ↗
$0Bought
$45KSold
NoneLast buy
Every filing
1 filing since Feb 2024, newest first
Filings come from SEC EDGAR. Not investment advice.